Body Hair Transplant Donor Sites: A Site-by-Site Clinical Guide

Introduction: When the Scalp Runs Out of Options

The average scalp donor area yields approximately 6,000 harvestable follicular units. For patients with advanced Norwood 5 through 7 baldness, this finite supply can be exhausted across one or more prior surgeries, leaving them with limited options for further restoration. Body hair transplantation offers a strategic supplemental solution that expands candidacy for patients previously told they have no remaining options.

The clinical relevance of body hair transplantation continues to grow. Repair procedures rose to 6.9% of all hair transplants in 2024, up from 5.4% in 2021, creating a significant patient population with depleted scalp donor areas seeking alternative solutions. This guide provides a site-by-site clinical breakdown of each body hair donor region, covering yield capacity, survival rates, growth characteristics, and ideal placement zones for beard, chest, stomach, legs, and arms.

FUE (Follicular Unit Extraction) is the only viable extraction method for body hair transplantation. FUT strip harvesting is not applicable to non-scalp sites due to scarring risk and anatomical limitations. This guide addresses clinical details including the test-case protocol, pre-operative minoxidil priming, anagen-phase shaving timing, and the practical implications of body hair retaining its original characteristics after transplantation.

Understanding Body Hair Transplantation: The Clinical Foundation

Body Hair Transplantation (BHT) involves using FUE to harvest follicles from non-scalp donor regions and transplant them to the scalp. These regions include the beard, chest, stomach, legs, arms, armpits, and pubic area. The primary clinical indications for BHT include Norwood 5 through 7 baldness, depleted scalp donor areas from prior surgeries, FUT strip scar repair, and patients with naturally limited scalp donor density.

According to the ISHRS 2025 Practice Census, BHT is attracting more interest among men and women as a supplemental option. Beard hair comprises 73.5% of all BHT cases, followed by chest at 13.3%, stomach at 4.8%, and leg at 2.4%.

BHT is technically demanding due to several factors: curved follicle growth paths beneath the skin, variable anagen cycles, and the need for specialized extraction tools. Historically, transection rates were 10 to 20% for beard and up to 30% for torso hair. Advancements in extraction technology, such as the UGraft Zeus device, have reduced average transection rates to below 7%, with beard grafts achieving approximately 4.8% and other body sites approximately 5.6%.

A key principle throughout body hair transplantation is that body hair retains its original characteristics after transplantation. The curl, color, caliber, and growth cycle do not adapt to scalp hair properties, which disproves recipient site dominance for body grafts.

A Critical Principle: Body Hair Does Not Become Scalp Hair

Recipient site dominance is the widely accepted principle that transplanted hair adapts to the characteristics of its new location. This principle does not apply to body hair grafts. A study of 35 patients published in PMC confirmed that transplanted body and beard hair do not change their color, curl, or caliber after transplantation to the scalp.

The practical implications are significant. Body hair will grow to a shorter maximum length than scalp hair due to a shorter anagen phase. It may shed more frequently and will retain its original texture; coarser beard hair will remain coarse on the scalp. These permanent characteristics mean that placement zones must be carefully selected, making strategic site selection essential for natural-looking results.

Body hair has a shorter anagen (growth) phase than scalp hair, meaning transplanted body hair will not grow as long. Patients should understand this before committing to BHT. Mixing body and scalp grafts, rather than using body hair alone, typically produces the most natural-looking results.

Beard Hair: The Gold Standard of Body Donor Sites

Beard hair is the most clinically preferred non-scalp donor source, comprising 73.5% of all BHT cases according to the ISHRS 2025 data. The reasons for this preference are compelling.

Peer-reviewed comparative data demonstrates that beard hair achieves approximately 94 to 95% survival at one year, outperforming scalp hair at 89% and far exceeding chest hair at 75 to 76%. Beard hair is also intrinsically resistant to the effects of testosterone and DHT, making transplanted beard grafts permanent.

Beard hair grows at approximately 0.4 mm per day, faster than other body sites at 0.2 to 0.35 mm per day, making it more productive post-transplant. While beard grafts typically contain only one hair follicle per unit (unlike scalp grafts with 2 to 3), the shaft is significantly thicker, providing substantial volume and coverage.

A single beard session can safely yield 1,000 to 3,000 grafts, the highest of any non-scalp donor site. Beard hair is best used as a filler for the mid-scalp, crown, and vertex. It is generally not recommended for the frontal hairline due to its coarse texture. The submental region (under the chin) is a particularly productive harvest area within the beard zone. For a deeper look at how beard hair grafts perform in hair restoration, additional clinical detail is available.

Chest Hair: High Potential, High Complexity

Chest hair is the second most commonly used BHT donor site at 13.3% of BHT cases, but it presents significantly more technical challenges than beard hair.

One-year survival rates for chest hair are approximately 75 to 76%, lower than both beard and scalp hair, which requires adjusted patient expectations. Chest follicles often grow curved beneath the skin, making extraction technically demanding and increasing transection risk for less experienced surgeons.

Chest hair typically yields only 300 to 1,000 grafts safely per session, significantly lower than beard. A unique challenge with chest sites is achieving adequate anesthesia, which is particularly difficult due to nerves running under the rib cage and proximity to vital organs. This is a key practical concern and a reason why only specialized surgeons should perform chest hair extraction.

Chest hair tends to be finer than beard hair, which can be advantageous for certain placement zones but also means less coverage per graft. Like all body hair, chest hair retains its original curl and caliber post-transplant. Chest hair can supplement beard and scalp grafts for mid-scalp and crown filling, particularly in patients with limited beard density.

Stomach (Abdominal) Hair: A Limited but Viable Reserve

Stomach hair is a tertiary donor option, comprising 4.8% of BHT cases. It is used primarily when beard and chest supplies are insufficient.

Abdominal hair typically has lower density compared to beard and chest, which limits total harvestable graft counts. Abdominal hair tends to be fine and soft in texture, which can be an advantage for certain placement zones requiring less coarse coverage.

Abdominal skin is more mobile and elastic than scalp skin, which can complicate follicle extraction and requires experienced technique. Survival rates for stomach hair are generally in line with other torso sites (lower than beard), and the shorter anagen phase applies here as well.

Stomach hair is best suited as a supplemental volume source for the crown and vertex in patients with depleted primary donor areas. It is rarely used as a primary donor source and is most valuable as part of a multi-site harvesting strategy in complex cases.

Leg Hair: The Underrated Option for Hairline Refinement

Leg hair is a niche but clinically valuable donor source, comprising 2.4% of BHT cases. It is underutilized relative to its potential for specific applications.

The key differentiating advantage of leg hair is its typically fine and soft texture, making it one of the few body donor sources suitable for frontal hairline reconstruction where a natural, soft edge is required. Nape hair from the back of the neck shares similar fine characteristics and is sometimes used alongside leg hair for hairline work.

Leg hair harvest is limited by density and the large surface area required to collect meaningful graft counts, typically resulting in lower per-session yields than beard or chest. Leg hair has one of the shorter anagen phases among body hair sites, meaning transplanted leg hair will have a shorter maximum growth length.

Harvesting from legs requires patient positioning adjustments and covers a large skin surface area, adding procedural time. Leg hair is most valuable for creating soft, natural-looking hairline edges in combination with scalp grafts, not for high-volume crown or mid-scalp filling.

One documented case demonstrated the outer limits of multi-site BHT, using 7,000 grafts from leg, calf, and other non-scalp/non-beard body sites to cover an entire bald scalp.

Arm Hair and Other Sites: Expanding the Donor Map

Arm hair serves as an additional supplemental donor source with fine texture similar to leg hair and similar limitations in density and yield. Armpit and pubic hair have been documented as donor sites used in extreme cases, representing the outer boundaries of BHT.

These peripheral sites share common characteristics: fine hair, low density, short anagen phases, and lower survival rates compared to beard. They are typically only considered when all primary donor sources (scalp, beard, chest) have been exhausted or are unavailable.

Harvesting from these areas requires extensive body shaving and longer procedural sessions. Multi-site harvesting strategies that combine scalp, beard, and supplemental body sites produce the most comprehensive results for advanced cases.

Donor Site Comparison: A Clinical Reference Summary

Beard:

• Graft yield: 1,000 to 3,000 per session
• Survival rate: 94 to 95%
• Texture: Coarse, thick
• Growth rate: 0.4 mm/day
• DHT resistant: Yes
• Best placement: Mid-scalp, crown, vertex

Chest:

• Graft yield: 300 to 1,000 per session
• Survival rate: 75 to 76%
• Texture: Medium
• Growth rate: 0.2 to 0.35 mm/day
• Extraction challenges: Curved follicles, anesthesia difficulty
• Best placement: Mid-scalp, crown supplement

Stomach:

• Graft yield: Lower than chest
• Survival rate: Similar to other torso sites
• Texture: Fine to medium
• Best placement: Crown, vertex supplement

Legs:

• Graft yield: Limited
• Texture: Fine, soft
• Best placement: Hairline refinement, soft edges

Arms/Other:

• Graft yield: Lowest
• Texture: Fine
• Best placement: Last-resort supplemental sources

Overall BHT success rates range from 50 to 80% depending on donor site, compared to standard scalp FUE at 90 to 95%. Mixing body and scalp grafts produces the most natural results, with scalp hair for the hairline and frontal zone and body hair for mid-scalp and crown.

Pre-Operative Protocols: Preparing Body Donor Sites for Success

BHT outcomes are significantly influenced by pre-operative preparation. Applying 5% minoxidil to body donor areas 6 weeks to 6 months before surgery shortens the telogen phase and increases hair caliber, improving both yield and graft quality.

Body donor areas should be shaved 7 to 10 days before surgery (2 to 3 days for beard). This timing allows surgeons to identify late-phase anagen hairs, which are the most viable for transplantation. Harvesting hairs in the correct growth phase significantly impacts survival rates and reduces wasted extraction attempts. Patients considering whether shaving is required before an FUE hair transplant will find that similar timing principles apply to body donor sites.

Post-operative minoxidil use, starting 5 to 7 days after surgery, is also recommended to support graft survival and minimize shock loss. BHT procedures typically take 8 to 9 hours per session, with approximately 1,500 to 1,800 grafts transplantable per day.

Adjunct regenerative therapies can enhance outcomes. ACell (extracellular matrix) combined with PRP/CRP has been shown to enhance BHT graft survival, particularly in scar tissue environments. One documented case showed 92% survival of beard grafts in ACell-treated scar tissue. For more on how ACell PRP treatment supports graft survival, additional clinical data is available.

The Test-Case Protocol: A Critical Step Before Full BHT Commitment

The test-case protocol is a standard of care recommendation that involves transplanting 50 to 500 body hair grafts before committing to a full BHT session. This approach estimates yield, assesses survival rates for that specific patient, and allows the patient to evaluate aesthetic results.

Individual variation in body hair density, follicle angle, and growth characteristics means that published survival rates are population averages. A test case provides patient-specific data and allows patients to see how their specific body hair looks and grows on the scalp before undergoing a full multi-session commitment.

The test case is particularly important for chest and torso sites, where survival rates are more variable and extraction is more technically challenging. Test case results are typically evaluable at 6 to 12 months, meaning patients should factor this into their overall treatment timeline. This represents responsible clinical practice that protects both patient outcomes and surgeon credibility.

Who Is a Candidate for Body Hair Transplantation?

The primary candidate profile includes patients with Norwood 5 through 7 baldness, depleted scalp donor areas from prior surgeries, or naturally limited scalp donor density. Patients with botched prior surgeries, including FUT strip scars, represent a growing and underserved population. In a published 122-patient BHT case series, over half (53.3%) had BHT combined with strip scar repair.

Many of these patients have been told they are not candidates for further hair restoration. BHT changes that prognosis, which carries significant emotional weight for patients who had lost hope. The emotional impact of hair loss on self-confidence and mental health is a meaningful factor in why these patients pursue every available option.

Patients who are not good BHT candidates include those with insufficient body hair density, active skin conditions at donor sites, unrealistic expectations about body hair characteristics post-transplant, or medical contraindications to extended surgical sessions. Comprehensive donor assessment that evaluates all available donor capital before developing a lifetime treatment plan is essential.

Donor Capital Planning: A Lifetime Strategic Perspective

Donor capital planning treats all available hair (scalp plus body) as a finite strategic reserve to be allocated across a patient’s lifetime of procedures. Hair loss is progressive, and decisions made in a patient’s 30s about donor allocation will affect options available in their 50s and 60s.

The sequencing logic is straightforward: scalp donor hair should generally be prioritized for the hairline and frontal zone (highest visual impact, requires finest texture), while body hair is reserved for mid-scalp and crown filling. Over-harvesting any single donor site creates risk; depleting the beard donor area in an early procedure removes it as a resource for future sessions.

The global hair transplant market’s growth, projected from $10.74 billion in 2026 to $59.89 billion by 2035, is driving increased interest in BHT for complex cases. Patients considering BHT should work with surgeons who take a comprehensive, multi-decade planning approach rather than optimizing for a single session. Understanding when is the right time to get a hair transplant is an important part of this long-term planning process.

What to Expect: Outcomes, Timelines, and Managing Expectations

Realistic outcome expectations are essential. BHT overall success rates range from 50 to 80% depending on donor site, compared to standard scalp FUE at 90 to 95%. Body hair transplants follow a similar initial shedding and regrowth cycle to scalp transplants, but the shorter anagen phase means final length will be limited.

Transplanted beard hair on the scalp will require trimming to manage length, and its coarser texture may require styling adjustments. Achieving comprehensive coverage for advanced Norwood patients using BHT typically requires multiple sessions over 12 to 24 months or more. Reviewing a hair transplant growth timeline month by month can help patients set realistic expectations for when results become visible.

BHT works best as part of a comprehensive plan that may include medical therapies (minoxidil, finasteride) to preserve remaining native hair and regenerative therapies to support graft survival. A 2024 multicenter study confirmed significantly improved graft survival and low transection rates with advanced extraction technology, demonstrating that outcomes are improving as the field advances.

BHT is more technically demanding, more expensive, and performed by only a small number of specialized surgeons worldwide. Patients should research hair transplant surgeon credentials carefully.

Conclusion: Body Hair Transplantation as a Strategic Clinical Tool

Body hair donor sites are not a fallback option but a sophisticated clinical tool that, when understood at a technical level, can restore candidacy for patients with advanced hair loss or depleted scalp donor areas. The site-by-site hierarchy is clear: beard hair is the gold standard with the highest survival, best yield, and DHT resistance; chest hair offers meaningful supplemental volume with greater technical demands; and finer sites like legs provide specialized value for hairline refinement.

The non-negotiable clinical realities remain: body hair retains its original characteristics post-transplant, survival rates are lower than scalp FUE, and success depends heavily on surgeon expertise and pre-operative preparation. With repair procedures rising and the global hair restoration market expanding, more patients will benefit from understanding these options.

The best outcomes come from comprehensive donor capital planning that treats all available hair as a strategic resource to be allocated thoughtfully across a patient’s lifetime. Patients who have been told they have run out of options may have more possibilities than they realize, but realizing those possibilities requires working with surgeons who have deep, specialized expertise in BHT.

Ready to Explore Your Full Donor Potential? Consult With Shapiro Medical Group

Shapiro Medical Group is a Minneapolis-based hair restoration practice with over 30 years of exclusive focus on hair transplantation since 1990. Dr. Ron Shapiro co-authored the leading hair transplant textbook, referred to by physicians as the “Hair Transplant Bible,” and the team has lectured at over 100 conferences in more than 20 countries.

The one-patient-per-day policy is directly relevant to BHT patients. Complex body hair cases require the kind of focused, individualized attention that this model provides. Shapiro Medical Group serves both local Minneapolis patients and out-of-state and international patients, with established protocols for those traveling for care.

Patients who believe they may have exhausted their scalp donor options should schedule a consultation to explore whether body hair donor sites could expand their candidacy. Physicians from other practices choose Shapiro Medical Group for their own procedures, a powerful endorsement of clinical excellence. Visit shapiromedical.com to schedule a consultation or contact the patient coordinator team.